Donald K. Stern, Director at NOVELION THERAPEUTICS INC. (NVLN), bought 2,500 shares at $9.10 ($23K) on 2017-06-12, disclosed to the SEC on 2017-06-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.